359 related articles for article (PubMed ID: 31821572)
1. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
[TBL] [Abstract][Full Text] [Related]
2. Survival analysis of patients with advanced hypopharyngeal cancer comparing patients who received primary surgery to those who received chemoradiation: An analysis of the NCDB.
Hochfelder CG; Mehta V; Kabarriti R; McGinn AP; Castellucci E; Ow TJ
Oral Oncol; 2021 Oct; 121():105470. PubMed ID: 34418696
[TBL] [Abstract][Full Text] [Related]
3. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
[TBL] [Abstract][Full Text] [Related]
4. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
Gootee J; Patel M; Aurit S; Silberstein P
Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
6. Oncological outcomes from surgical vs. non-surgical treatments for advanced hypopharyngeal squamous cell carcinoma: a surveillance, epidemiology, and end results-based study.
Fan Y; Li S; Xia X; Yu S; Zhu X; Zhu Y; Diao W; Chen X
Clin Transl Oncol; 2022 Dec; 24(12):2379-2387. PubMed ID: 35882729
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
8. Locally advanced hypopharyngeal and laryngeal cancer: Influence of HPV status.
Bates JE; Morris CG; Hitchcock KE; Dziegielewski PT; Mendenhall WM; Amdur RJ
Radiother Oncol; 2019 Nov; 140():6-9. PubMed ID: 31174105
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma.
Tsai YT; Chen WC; Chien CY; Hsu CM; Lee YC; Tsai MS; Lin MH; Lai CH; Chang KP
World J Surg Oncol; 2020 May; 18(1):82. PubMed ID: 32357934
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
Giacalone NJ; Qureshi MM; Mak KS; Kirke D; Patel SA; Shah BA; Salama AR; Jalisi S; Truong MT
Laryngoscope; 2018 Apr; 128(4):831-840. PubMed ID: 28833217
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
[TBL] [Abstract][Full Text] [Related]
12. Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
Kim JW; Kim MS; Kim SH; Kim JH; Lee CG; Kim GE; Keum KC
Cancer Res Treat; 2016 Jan; 48(1):45-53. PubMed ID: 25779363
[TBL] [Abstract][Full Text] [Related]
13. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
14. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Survival Outcomes Between Larynx-Preserving Open Partial Pharyngectomy and Radiotherapy or Chemoradiotherapy in Patients with Hypopharyngeal Squamous Cell Carcinoma: A Single-Center Retrospective Analysis with Inverse Probability of Treatment Weighting Adjustments.
Eguchi K; Omura G; Murakami N; Honma Y; Yokoyama K; Watanabe T; Aihara Y; Sakai A; Matsumoto Y; Sakai T; Kobayashi K; Igaki H; Yoshimoto S
Ann Surg Oncol; 2023 Oct; 30(11):6867-6874. PubMed ID: 37452169
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemoradiotherapy versus with radiotherapy alone for locally advanced salivary gland carcinoma among older patients.
Tanvetyanon T; Fisher K; Caudell J; Otto K; Padhya T; Trotti A
Head Neck; 2016 Jun; 38(6):863-70. PubMed ID: 26340707
[TBL] [Abstract][Full Text] [Related]
17. Predicting Factors for Oncological and Functional Outcome in Hypopharyngeal Cancer.
Visini M; Giger R; Shelan M; Elicin O; Anschuetz L
Laryngoscope; 2021 May; 131(5):E1543-E1549. PubMed ID: 33098325
[TBL] [Abstract][Full Text] [Related]
18. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
[No Abstract] [Full Text] [Related]
19. Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer.
Petersen JF; Arends CR; van der Noort V; Al-Mamgani A; de Boer JP; Stuiver MM; van den Brekel MWM
Oral Oncol; 2019 Aug; 95():143-149. PubMed ID: 31345382
[TBL] [Abstract][Full Text] [Related]
20. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]